glp 1 agonist new drug List of approved and pending GLP-1 medications Retatrutide for weight loss: Study

Among the most promising treatments we provide are GLP-1 medications, a specialized class of medications known as glucagon-like peptide-1 receptor agonists

Retatrutide is an investigational drug that is not approved by the FDA or EMA for any use

Methods Animals Adult male Sprague-Dawley rats (Charles River Laboratories, USA) were individually housed in double-wide cages with a temperature and humidity-controlled environment on a 12-hour/12-hour light-dark cycle

Genetically predicted glucose-dependent Insulinotropic polypeptide (GIP) levels and Cardiovascular Disease Risk are driven by distinct causal variants in the GIPR Region

Many patients continue to experience symptoms long after discontinuing the medication